Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Chlorhexidine
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
=== Topical ===<!-- This section is redirected to from [[Septol]]. --> Chlorhexidine gluconate is used as a skin cleanser for surgical scrubs, as a cleanser for skin wounds, for preoperative skin preparation, and for germicidal hand rinses.<ref name="tox" /> Chlorhexidine [[eye drop]]s have been used as a treatment for eyes affected by [[Acanthamoeba keratitis|''Acanthamoeba'' keratitis]].<ref name="Alkharashi">{{cite journal | vauthors = Alkharashi M, Lindsley K, Law HA, Sikder S | title = Medical interventions for acanthamoeba keratitis | journal = The Cochrane Database of Systematic Reviews | volume = 2015 | issue = 2 | pages = CD010792 | date = February 2015 | pmid = 25710134 | pmc = 4730543 | doi = 10.1002/14651858.CD010792.pub2 }}</ref> Chlorhexidine is a very effective antiseptic and its use is growing in the world for treating the umbilical cord. A 2015 [[Cochrane review]] has yielded high-quality evidence that within the community setting, chlorhexidine skin or cord care can reduce the incidence of [[omphalitis]] (inflammation of the [[umbilical cord]]) by 50% and neonatal mortality by 12%.<ref>{{cite journal | vauthors = Sinha A, Sazawal S, Pradhan A, Ramji S, Opiyo N | title = Chlorhexidine skin or cord care for prevention of mortality and infections in neonates | journal = The Cochrane Database of Systematic Reviews | volume = 2015 | issue = 3 | pages = CD007835 | date = March 2015 | pmid = 25739381 | doi = 10.1002/14651858.CD007835.pub2 | s2cid = 16586836 | pmc = 10638659 }}</ref>
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)